Literature DB >> 3285214

Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.

P J Boyle1, N S Schwartz, S D Shah, W E Clutter, P E Cryer.   

Abstract

We tested the hypothesis that during decrements in plasma glucose concentration, symptoms of hypoglycemia may occur at higher glucose concentrations in patients with poorly controlled insulin-dependent diabetes mellitus than in persons without diabetes. Symptoms of hypoglycemia and counterregulatory neuroendocrine responses were quantified during hypoglycemic and euglycemic clamp studies in eight patients with insulin-dependent diabetes mellitus selected because their hemoglobin A1 levels were above 10 percent. These data were compared with similar observations in 10 nondiabetic subjects studied previously. Glycemic thresholds--the plasma glucose concentrations during each hypoglycemic clamp study at which a given symptom or biochemical measurement first exceeded its 95 percent confidence interval determined in the euglycemic clamp studies--were calculated for each variable. The mean (+/- SE) glycemic threshold for the symptoms of hypoglycemia was 4.3 +/- 0.3 mmol per liter (78 +/- 5 mg per deciliter) in patients with poorly controlled diabetes--significantly higher (P less than 0.001) than the value of 2.9 +/- 0.1 mmol per liter (53 +/- 2 mg per deciliter) in subjects without diabetes. The mean glycemic thresholds for growth hormone, epinephrine, and cortisol secretions were not significantly different in the two groups. Thus, during decreases in the plasma glucose concentration, patients with poorly controlled insulin-dependent diabetes mellitus may experience symptoms of hypoglycemia at higher plasma glucose concentrations than persons without diabetes. The mechanism underlying this observation remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285214     DOI: 10.1056/NEJM198806093182302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  48 in total

Review 1.  Severe hypoglycemia in adults.

Authors:  Mary F Carroll; Mark R Burge; David S Schade
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

Authors:  C Berne; J Fagius; T Pollare; P Hjemdahl
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

3.  Hormone response of diabetic patients to exercise at cool and warm temperatures.

Authors:  T Rönnemaa; J Marniemi; A Leino; H Karanko; P Puukka; V A Koivisto
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 4.  Hypoglycemia in type 1 diabetes mellitus.

Authors:  Philip E Cryer
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

5.  [Hypoglycemia despite hyperglycemia. Is a cerebral glucose deficiency possible even with raised blood sugar levels?].

Authors:  G Erdös; R Lobmann; B Wolcke; C Werner
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

6.  Preventing hypoglycaemia: what is the appropriate glucose alert value?

Authors:  P E Cryer
Journal:  Diabetologia       Date:  2008-11-19       Impact factor: 10.122

7.  Hypoglycemia in diabetes among children and adolescents.

Authors:  M M Karp
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

8.  Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse.

Authors:  E M Cornford; S Hyman; M E Cornford; M Clare-Salzler
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

Review 9.  Preventing diabetes-related morbidity and mortality in the primary care setting.

Authors:  Samuel Dagogo-Jack
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

10.  Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia.

Authors:  T S Trovik; A Vaartun; R Jorde; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.